CIR Vaccine Trials – Currently Enrolling

Project SAVE (Support a Vaccine Effort) is the adult recruitment program at the Center for Immunization Research.  The program is used to screen adult potential study participants to help determine their eligibility for specific clinical vaccine studies at the CIR.  Check below for studies that are currently enrolling.

Inpatient

Zika Vaccine Inpatient Study (CIR 316)

The purpose of this study is to learn about the clinical presentation and duration of shedding of the Zika virus in healthy adults.  The study is:

  • 6 months long
  • enrolling FEMALES ONLY 18-40 years old
  • includes 2-3 screening visits, one 16 day inpatient stay and 11 outpatient follow up visits
  • pays up to $5025 for completion of all study procedures

Complete the CIR Contact Form

More about  Zika Virus

Learn More
Shigella Inpatient Study (CIR 337)

The purpose of this study is to evaluate the cross-species protection conferred by a re-challenge with a Shigella species of a different serotype.  The study (is):

  • enrolling 18-50 year olds
  • includes 1 or 2 ten day inpatient stays* (about 3-4 months apart)
  • 4-5 outpatient visits after each inpatient stay
  • Pays $3000 for one admission
  • Pays $5750 for two admissions

*not all subjects will be selected to return for admission 2

Complete the CIR Contact Form

Learn More

Outpatient

Dose Study to Protect Against Dengue Virus (CIR 332)

The purpose of this study is to evaluate the safety and efficacy of repeated oral doses to protect against exposure to dengue virus.  The study (is):

  • 3 months long
  • 2-3 screening visits
  • 29 consecutive daily visits for oral dosing of medication
  • 2 two-night inpatient stays
  • 1 Dengue challenge visit
  • 8 follow up visits
  • pays up to $4910 for completion of all study procedures

Complete the CIR Contact Form

More about Dengue Virus

Learn More
Yellow Fever Vaccine Study (CIR 333)

The purpose of this study is to demonstrate that a new (investigational) yellow fever vaccine is as safe and protective against yellow fever infection as the currently licensed yellow fever vaccine.  The study (is):

  • enrolling 18-60 year olds
  • includes 1 vaccination day visit
  • includes 9-10 follow up visits over 5 years
  • Pays $870-950 depending on visits completed

Complete the CIR Contact Form

Learn More
Translate »